Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients

Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients

Abstract Background Antibody response to SARS-CoV-2 is a valuable biomarker for the assessment of the spread of the virus in a population and evaluation of the vaccine candidates. Recent data suggest that antibody levels also may have a prognostic significance in COVID-19. Most of the serological st...

Full description

Bibliographic Details
Main Authors: Jānis Plūme, Artis Galvanovskis, Sindija Šmite, Nadezhda Romanchikova, Pawel Zayakin, Aija Linē
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Journal of Translational Medicine
Subjects:
SARS-CoV-2
Antibody profile
Antigen microarray
Prognosis
IgG
IgA
Online Access:https://doi.org/10.1186/s12967-022-03382-y

Internet

https://doi.org/10.1186/s12967-022-03382-y

Similar Items